MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Association Between Pesticide Exposure and Clinical Outcomes in Parkinson’s Disease: A Propensity-Matched Cohort Study

    C. Cerquera-Cleves, G. Pinilla-Monsalve, M. Blais, M. Cressati, C. Normandeau, C. Degroot, I. Kathol, S. Bogard, A. Bendas, R. Camicioli, Z. Gan-Or, DA. Grimes, K. Schoffer, LV. Kalia, PA. Macdonald, MJ. Mckeown, D. Martino, J. Miyasaki, M. Schlossmacher, AJ. Stoessl, A. Strafella, E. Fon, O. Monchi, N. Dupré, F. Cicchetti (Québec, Canada)

    Objective: To evaluate the clinical outcomes associated with pesticide exposure in Parkinson’s disease (PD) participants in the Canadian Open Parkinson Network (COPN)(1). Background: Pesticide exposure…
  • 2025 International Congress

    Comparison of clinical symptoms between young-onset and elderly-onset in patient with early Parkinson’s disease

    M. Iijima, R. Morimoto, K. Suzuki, S. Nogawa, Y. Okuma (Tokyo, Japan)

    Objective: We compared the clinical symptoms of early Parkinson's disease (PD) between young-onset and elderly-onset. Background: The progression of PD varies depending on the age…
  • 2025 International Congress

    Ethnicity in Parkinson’s Disease: A Brazilian Cross-sectional Study

    J. Oliveira, G. Nunes, N. Dos Santos, F. Brito, J. Costa, E. Muricy, G. de Vasconcelos, S. Baran, R. Kauark (Salvador, Brazil)

    Objective: To investigate clinical characteristics of PD patients and their association with ethnicity at a reference center for movement disorders. Background: It is well known…
  • 2025 International Congress

    The Unique Clinical Profile of Dystonia in Parkinson Disease

    L. Xavier, A. Eid, H. Hwang, J. Perlmutter, P. Kotzbauer, M. Campbell, S. Norris (Saint Louis, USA)

    Objective: Characterize clinical features of dystonia and levodopa-related dyskinesias in Parkinson disease (PD). Background: Dystonia affects 30-60% of individuals with PD. [1] Despite recognition as…
  • 2025 International Congress

    The Movement Disorders Society Unified Parkinson Disease Rating Scale Motor Subscore Is Not Associated With Future Parkinson Disease Milestones – an observational study using linked health administrative data

    P. Gros, S. Bronskill, S. Dorrance, X. Wang, M. Chiu, M. Farkouh, C. Marras (Toronto, Canada)

    Objective: To examine the association between time to Parkinson Disease (PD) health administrative data milestones and a one-year change in the Movement Disorders Society –…
  • 2025 International Congress

    Heterogeneity of the First Clinical Manifestations Reported in Patients with Early- and Late-Onset Parkinson’s Disease.

    J. Trejo-Ayala, H. Trujillo-Guerra, J. Sánchez-Garza, D. Ortiz-Zacarías, S. Castillo-Torres, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

    Objective: To compare the onset of clinical manifestations by location and motor or non-motor symptoms in patients with early- and late-onset Parkinson’s Disease (PD) from a movement…
  • 2025 International Congress

    Finding Prodromal Parkinson’s Disease with the Movement Disorder Society’s Prodromal Calculator and Electronic Health Records

    J. Heller, K. Fitzgerald (Baltimore, USA)

    Objective: To explore the ability for electronic health records to identify persons with prodromal Parkinson’s disease in a cohort of those with RBD in the…
  • 2025 International Congress

    Tendencies of Non-Motor Symptoms and Short-Term Clinical Predictors in Patients with Parkinson’s Disease

    R. Nakagawa, M. Shiraishi, N. Takao, H. Matsumoto (Kawasaki City, Kanagawa Prefecture, Japan)

    Objective: This study retrospectively investigated whether the occurrence of non-motor symptoms and the decline in cognitive function in patients with Parkinson’s disease (PD) influence fall…
  • 2025 International Congress

    Investigating the role of NLRP3 Inflammasome as Biomarkers and Therapeutic Targets in Parkinson’s Disease Pathogenesis

    S. Choudhury, N. Kamble, V. Holla, S. M, P. Pal, R. Yadav, P. Alladi (Bangalore, India)

    Objective: To elucidate the role of NLRP3 Inflammasome in PD pathogenesis and its role in differential susceptibility. Background: Inflammasomes play a role in the progression…
  • 2025 International Congress

    The Bjorn Moller Research Repository: A Resource for Movement Disorders Research

    S. Schaffner, A. Kuan, D. Felix, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To build a repository of longitudinally collected biological samples and clinical, demographic, and lifestyle data from individuals with Parkinson’s disease (PD) and other movement…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley